Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

May 16, 2018 11:41 PM UTC

FDA approved Lucemyra lofexidine from US WorldMeds LLC (Louisville, Ky.) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. According to the agency, Lucemyra is the first non-opioid drug approved by FDA to manage opioid withdrawal symptoms.

US WorldMeds did not respond to inquiries regarding its launch plans or pricing details...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article